Cancer News and Research

Latest Cancer News and Research

MedQuist integrates DEP with new features of Epic Systems' Hyperspace Client

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is integrating with Epic Systems Corporation within its Hyperspace environment to offer a solution that integrates "partial dictations" with the template-based clinical documentation process, enabling physicians to complete the Electronic Health Record (EHR) without changing their documentation workflow.

27 Feb 2010

Cell Therapeutics files 2009 Annual Report on Form 10-K

Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.

27 Feb 2010

CHI lauds California state Assembly's proclamation of Feb. 28, as Rare Disease Day

CHI-California Healthcare Institute, a non-profit public policy research organization, applauds the state Assembly’s proclamation of Feb. 28, as Rare Disease Day. This day helps bring awareness of the biomedical companies that are dedicated to researching and developing treatments for patients suffering from rare diseases.

27 Feb 2010

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Geoffrey I. Shapiro of Dana-Farber Cancer Institute, presented preclinical and clinical data on STA-9090, a potent second-generation Hsp90 inhibitor, at IASLC (International Association for the Study of Lung Cancer) 10th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting in Santa Monica, CA.

27 Feb 2010

NIH awards $3M grant to VCU Massey Cancer Center to develop test to measure health literacy of cancer patients

The National Institutes of Health has awarded the Virginia Commonwealth Massey Cancer Center a National Cancer Institute grant totaling nearly $3 million to develop a standardized test to measure health literacy among cancer patients.

27 Feb 2010

Micrometastases in axillary lymph nodes associated with poorer overall survival in breast cancer patients

Metastases that were 2 millimeters or less in diameter ("micrometastases") in axillary lymph nodes detected on examination of a single section of the lymph nodes were associated with poorer disease-free and overall survival in breast cancer patients, according to a new study published online February 26 in the Journal of the National Cancer Institute.

27 Feb 2010

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Medicare regulations require that when patients receive some types of highly specialized cancer treatments, their radiation oncologist must be on site. But The New York Times reports that federal officials are investigating a Florida cancer clinic that billed Medicare for such treatments while the doctors were absent, sometimes on overseas trips.

27 Feb 2010

Fact-checks of the bipartisan health care summit

News outlets fact-check the bipartisan health care summit and provide analyses of the messaging and poll numbers lawmakers used during the six-hour event.

27 Feb 2010

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia.

27 Feb 2010

Medical innovation and research: A real boon for American patients to live longer, healthier

An article in the Suislaw News recently highlighted the fact that medical innovation and research are enabling many people to live longer, healthier and more productive lives.

26 Feb 2010

Gene signature may help identify risk of colon cancer recurrence

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

26 Feb 2010

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Wound Management Technologies, Inc. announced today that the recent increase in sales activities throughout the United States has resulted in 45 new clinicians evaluating their advanced wound care collagen product, CellerateRx® . In the last two months, these evaluations have transpired into new customers in Arizona, New Mexico, South Carolina, North Dakota, New Jersey, Wyoming, Colorado, and New York.

26 Feb 2010

Hypnosis may help reduce pain and suffering in metastatic breast cancer patients

Hypnosis can help alleviate the pain and suffering experienced by women being treated for breast cancer, according to a study by a University at Buffalo School of Social Work professor.

26 Feb 2010

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list

Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.

26 Feb 2010

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.

26 Feb 2010

Notch-blocking drug effective against brain cancer stem cells, but more than one targeted attack needed

Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells - a small population of cells within tumors that perpetuate cancer growth - conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done.

26 Feb 2010

Widely used biomarkers in early detection of liver cancer are not ideal: Study

Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month's Gastroenterology.

26 Feb 2010

First Edition: February 26, 2010

It's the day after the White House health summit and the headlines are focused on what went on yesterday and what will happen next.

26 Feb 2010

Larynx preservation using chemotherapy followed by radiation is effective treatment: Study

Head and neck cancer patients receiving induction chemotherapy followed by radiation to preserve their larynx have a low-risk of severe voice disability and almost half experienced no eating or swallowing problems, according to a first of its kind study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

26 Feb 2010

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that PadKit® Collection Kit, a transport kit using an intralabial device for the collection of gynecological samples, has been selected by the UCLA School of Nursing as the sample collection system for a comparative cytology study of cervical cancer.

26 Feb 2010

Cancer News and Research

Latest Cancer News and Research

MedQuist integrates DEP with new features of Epic Systems' Hyperspace Client

Cell Therapeutics files 2009 Annual Report on Form 10-K

CHI lauds California state Assembly's proclamation of Feb. 28, as Rare Disease Day

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

NIH awards $3M grant to VCU Massey Cancer Center to develop test to measure health literacy of cancer patients

Micrometastases in axillary lymph nodes associated with poorer overall survival in breast cancer patients

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Fact-checks of the bipartisan health care summit

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Medical innovation and research: A real boon for American patients to live longer, healthier

Gene signature may help identify risk of colon cancer recurrence

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Hypnosis may help reduce pain and suffering in metastatic breast cancer patients

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Notch-blocking drug effective against brain cancer stem cells, but more than one targeted attack needed

Widely used biomarkers in early detection of liver cancer are not ideal: Study

First Edition: February 26, 2010

Larynx preservation using chemotherapy followed by radiation is effective treatment: Study

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in